An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

Phase 1 Completed 40 enrolled Merck Sharp & Dohme LLC

Non-randomizedSingle-groupOpen-labelPrevention

Summary

To prove that quadrivalent HPV (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine is generally safe and well tolerated in the Chinese population.

Timeline

Start: 2008-03
Primary completion: 2008-04
Completion: 2008-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gardasil	Vaccine	0.5 ml	Other

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

Summary

Timeline

Drugs

Indications